25-10-2012
1
Societeit “De Vereeniging” Utrecht
Het Orphan Café wordt voor de derde maal georganiseerd
door het Projectteam Zeldzame Ziekten en is
mogelijk gemaakt door de steun van:
Programma
15.00 inloop
15.30 Programma
Johan Hanstede
update over het Adviespunt Zeldzame Ziekten.
Frits Lekkerkerker
Toelichting op het Nationaal Plan Zeldzame Ziekten
Nicole Kien
spreekt over patiënten met zeldzame ziekten, vergoedingen, trends en casuïstiek.
17.00 uur Netwerkborrel
25-10-2012
2
Advise Center Orphan Diseases
The Netherlands
Johan Hanstede,
Chairman Project Team Orphan Diseases
Strategic Advisor BioFarmind
Chairman Dutch Vaccines Group
Director DutchCC
Overview of the current situation
• Pharmaceutical imago
• Price Transparency and CE Orphan Drugs
• Cost of Care reduction
• Pharmacy Manufacturing
• Public Development Orphan Drugs
• Public commitment towards orphan diseases’
• Particular treatment. How long particular?
• Transfer of orphan drugs to hospital budget
Identification of key ongoing issues in our market
25-10-2012
3
Ongoing developments and activities
National Plan Orphan Diseases Netherlands (2013)
Sounding board group Orphan Diseases
Expert Centers (2013)
Dutch Federation of University Medical Centers (NFU)
Foundation Advice Center Orphan Diseases (2013)
Project Team Orphan Diseases
Orphan Drug Project Team Eric van der Aa (Pantarhei Bioscience);
Roger Legtenberg (PSR-group);
Hans Schikan (Prosensa);
Paul Flapper (Shire Human Genetic Therapies);
Bert de Jong (Genzyme);
Peter Bertens (Nefarma);
Annemiek Verkamman(BioFarmind);
Marcel Gerritsen (BioFarmind);
Margaret van der Meijden (BPRA)
Jolanda Huizer (NPZZ/ ZonMw);
Johan Hanstede Chairman.
25-10-2012
4
“ Advice Center Orphan Diseases”
Central advice center For Business, Research Centers, Patiënt organizations and others
Monitoring OD activities (Clinical and R&D)
Questions & Answers
Portal as spin in a virtual web
Finding the Experts
Financial opportunities
Advice Center will be part of the National Plan OD Netherlands
Advice Center Orphan Diseases
R&D
TRM
Universities
Institutes
Companies
Media
Patients
Society
Authorities
Politics
Portal site
OD Network
OD Registry
OD Monitor
Training & Education
Signaling Function
Communication
25-10-2012
5
Critical Success Factors
Independent organization
Broad support
Strong Infrastructure
Continuity
Committee of Recommendation
Professional support OD Portal
Social image Orphan Drug development
Joining forces
Future potential outcomes
• Start with Advice Center will lead to
• Accelerating Time to Market
• Positive image OD
• Identify problems
• Potential threats
• Financial support
25-10-2012
6
Planned activities and next steps
2012/2013 Oct Nov Dec Jan Febr Mrt Apr May June July Aug Sept Oct Nov Dec
General
Orphan Café X X X X
Launch Symposium X
Sentiments monitor X
Orphan Disease Registry
ACZZ Business Plan X
Media & Com. Plan X
Training & Educational Plan X
E-learning Plan X
Organization
Organization structure X
Governance & Board X
Consortium & OD Network X
Funding
ZonMw Subsidary X
Innovation Contract LS&H
Crowd & Charaty
Letters of Intent (LOI)
Letters of Support (LOS) X
Portal site
Website Phase I
Website Phase 2
Website Phase 3 X
25-10-2012
7
Projectteam Orphan Diseases
Information / support
J.G.Hanstede, chairman
E-mail [email protected]
Mobile 06 5152 6780
Programma
15.00 inloop
15.30 Programma
Johan Hanstede
update over het Adviespunt Zeldzame Ziekten.
Frits Lekkerkerker
Toelichting op het Nationaal Plan Zeldzame Ziekten
Nicole Kien
spreekt over patiënten met zeldzame ziekten, vergoedingen, trends en casuïstiek.
17.00 uur Netwerkborrel
Top Related